Abbott

2022 - 8 - 12

Post cover — Image courtesy of "FierceBiotech"

Abbott brings €440M and 1000 jobs to Ireland to ramp up diabetes ... (FierceBiotech)

Abbott laid out plans to expand its production footprint in the country to boost its continuous glucose monitoring technologies.

US healthcare firm Abbott to invest €440m and create 1000 jobs in ... (BreakingNews.ie)

The expansion will make Ireland a leader in the production of high-tech diabetes glucose monitoring devices.

The Irish investment is just part of a global expansion by Abbott, which is the market leader in new tech diabetes glucose monitoring systems. Subject to planning approval, it hopes to open the new plant in 2024. The announcement marks a significant investment in Ireland by the US group, which already employs 5,000 people across a number of businesses in all four provinces.

Abbott to bring 1000 jobs to Kilkenny and Donegal from €440m ... (Siliconrepublic.com)

Abbott has announced plans to construct a new greenfield manufacturing facility in Kilkenny, along with further investment in its Donegal Diabetes Care site.

“It is also most welcome and demonstrates continued commitment to its Donegal site that it will benefit from further investment and new jobs.” It will be located at the IDA Business and Technology Park in Loughboy, subject to planning permission. Abbott’s FreeStyle Libre tech lets people with diabetes monitor their glucose level without routine fingerpicks.

Abbott to add 1000 jobs in $450 million Irish investment (Reuters)

U.S. healthcare company Abbott Laboratories plans to hire 1000 more people in Ireland in one of the biggest job announcements this year in the country's ...

Medtech giant Abbott to create 1000 new jobs in Kilkenny and ... (thejournal.ie)

US MEDTECH FIRM Abbott Technologies is to create 1,000 jobs in Kilkenny and Donegal as part of a €440 million investment in its presence here.

For the price of one cup of coffee each week you can help keep paywalls away. For the price of one cup of coffee each week you can help keep paywalls away. More than 5,000 readers have already pitched in to keep free access to The Journal.

Abbott will spend $450M to up FreeStyle Libre production in Ireland (Mass Device)

Abbott (NYSE:ABT) will spend €440 million ($450 million) to expand its operations in Ireland, the country's government announced today. The investment involves the creation of a new 250,000-square-foot manufacturing facility in Kilkenny and a further ...

The new plant in Kilkenny will still need to clear planning permission. The investment will add 1,000 new jobs between the sites. “Abbott has a long and successful history, first establishing operations in Ireland in 1946, and this new investment is a great vote of confidence in the workforce here and in this country as a place to invest,” Irish Taoiseach Micheál Martin said in a news release.

IDA Ireland welcomes Abbott expansion (Med-Tech Innovation)

IDA Ireland, together with taoiseach Micheál Martin and tánaiste Leo Varadkar, has welcomed news that Abbott is to construct a new greenfield manufacturing ...

I wish all the team at Abbott every continued success in its endeavours in the years to come.” The new 250,000 sq. “Abbott has a long and successful history, first establishing operations in Ireland in 1946, and this new investment is a great vote of confidence in the workforce here, and in this country as a place to invest.

Abbott pumps $450M+ into new Ireland-based manufacturing site ... (Endpoints News)

As Ireland continues to see more investments and building projects from pharma companies, another contender is looking to place more investment in the ...

And the company is bullish that it can find the talent. The site, which the company hopes to have online by 2024, will be responsible for the manufacture of its Freestyle Libre 3 system for continuous glucose monitoring. “Donegal is a key manufacturing site for Abbott’s diabetes care business, and we have invested heavily in expanding our operations there over the last four years.

Abbott investment puts Ireland in the fast lane (The Irish Times)

Jobs are always welcome but becoming a central part of fast-growing diabetes business is huge.

Abbott says the device will be offered at the same price as its existing Freestyle Libre 2 product line, which is already cheaper than its mainstream rivals. But, importantly, this move will place Ireland at the heart of Abbott’s diabetes division, which appears to be the fastest growing part of its empire. The decision to choose Kilkenny is in keeping with its history.

Abbott

Explore the last week